~~<i id='D13E23A267'><strike id='D13E23A267'><tt id='D13E23A267'><pre id='D13E23A267'></pre></tt></strike></i>~~

Home» leisure time» hotspot

hotspot

author：Wikipedia 2025-08-09 17:03:41 Page View：1

HHS 2020 — PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Biden declares emergency in flood
Next article： What does generative AI mean for health care? We asked experts

explore

Peter Hotez and the public health issue of online harassment

AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

IRA could hurt research into orphan drugs for rare diseases

AdobeThistimelastyear,membersofCongresswereworkingaroundtheclocktodraftandpasstheInflationReductionA

United colonoscopy coverage change 'may cost lives,' doctors say

AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

What to make of Biden’s latest efforts on cancer research

PresidentBidenspeaksontheCancerMoonshotinitiativeattheJohnF.KennedyLibraryin2022.EvanVucci/APWASHING